Millie
your market intelligence analyst
Search Results
325 results
Your search is now limited to «Roche» expert search.
ENDPOINTS 09/18/2019 07:27
Roche’s effort to introduce its blood cancer drug Gazyva to the immunology space just got a boost from the FDA.
More from ENDPOINTS:
pharmaphorum 09/18/2019 06:35
Roche’s Gazyva has won Breakthrough Therapy status for its potential new use in the autoimmune disease lupus nephritis, as the Swiss pharma attempts to breathe new life into the drug currently approved in leukaemia and lymphoma.
More from pharmaphorum:
Pharmafile 09/18/2019 03:46
Roche bags FDA Breakthrough for Gazyva in lupus nephritis.
More from Pharmafile:
ETHealthWorld (India) 09/18/2019 02:03
Roche has heralded Gazyva's potential in the new disease area in helping turn the drug that had sales of 390 million Swiss francs ($392.59 million) last year into a commercial success.
More from ETHealthWorld (India):
GlobeNewswire 09/18/2019 01:00
Roche has several investigational medicines in clinical development for immunological diseases including autoimmune disorders, rheumatoid arthritis, ulcerative colitis and Crohn's disease.
More from GlobeNewswire:
FiercePharmaManufacturing 09/17/2019 11:13
Assuming 60% to 70% “conservative” erosion from biosims, Roche could be looking at a sales gap of CHF 9.6 billion ($9.6 billion) between 2018 and 2023, Roche pharma chief Bill Anderson said at an investor event Monday.
More from FiercePharmaManufacturing:
FierceMedicalDevices 09/16/2019 10:58
Smaller biotechs are continuing their biopharma hiring spree as two startups nab some big names for their aspiring cancer drug research.
More from FierceMedicalDevices:
You can travel around the world without leaving Les Roches The friends, the studies and the opportunity to grow – Á lvaro believes his time at Les Roches prepared him well for a successful career in hospitality.
More from Les Roches International School of Hotel Management:
Hoffmann-La Roche (EU) 09/16/2019 01:00
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients.
More from Hoffmann-La Roche (EU):
World Pharma News 09/13/2019 04:00
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis.
More from World Pharma News:
Well, now skincare is set for a revolution as La Roche-Posay launches the ‘My Skin Track UV,' the first battery-free wearable sensor and companion app to measure the wearer's personal exposure to UV rays, pollution, humidity and pollen.
More from Middle East North Africa Financial Network (MENAFN):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications